Suppr超能文献

在抗生素治疗期间改变围手术期预防用药,并进行多次清创治疗骨科感染?

Changing perioperative prophylaxis during antibiotic therapy and iterative debridement for orthopedic infections?

机构信息

Orthopedic Surgery Service, Geneva University Hospitals, Geneva, Switzerland.

Infection Control Program, Geneva University Hospitals, Geneva, Switzerland.

出版信息

PLoS One. 2019 Dec 18;14(12):e0226674. doi: 10.1371/journal.pone.0226674. eCollection 2019.

Abstract

BACKGROUND

Perioperative antibiotic prophylaxis in non-infected orthopedic surgery is evident, in contrast to prophylaxis during surgery for infection. Epidemiological data are lacking for this particular situation.

METHODS AND FINDINGS

It is a single-center cohort on iterative surgical site infections (SSIs) in infected orthopedic patients. We included 2480 first episodes of orthopedic infections (median age 56 years and 833 immune-suppressed): implant-related infections (n = 648), osteoarticular infections (1153), and 1327 soft tissue infections. The median number of debridement was 1 (range, 1-15 interventions). Overall, 1617 infections (65%) were debrided once compared to 862 cases that were operated multiple times (35%). Upon iterative intraoperative tissue sampling, we detected pathogens in 507 cases (507/862; 59%), of which 241 (242/507; 48%) corresponded to the initial species at the first debridement. We witnessed 265 new SSIs (11% of the cohort) that were resistant to current antibiotic therapy in 174 cases (7% of the cohort). In multivariate analysis, iterative surgical debridements that were performed under current antibiotic administration were associated with new SSIs (odds ratio 1.6, 95%CI 1.2-2.2); mostly occurring after the 2nd debridement. However, we failed to define an ideal hypothetic prophylaxis during antibiotic therapy to prevent further SSIs.

CONCLUSIONS

Selection of new pathogens resistant to ongoing antibiotic therapy occurs frequently during iterative debridement in orthopedic infections, especially after the 2nd debridement. The new pathogens are however unpredictable. The prevention, if feasible, probably relies on surgical performance and wise indications for re-debridement instead of new maximal prophylactic antibiotic coverage in addition to current therapeutic regimens.

摘要

背景

与感染性手术的预防相比,非感染性骨科手术的围手术期抗生素预防是明确的。但在这种特殊情况下,缺乏流行病学数据。

方法和发现

这是一项针对感染性骨科患者手术部位感染(SSI)的单中心迭代队列研究。我们纳入了 2480 例骨科感染的首次发作(中位年龄 56 岁,833 例免疫抑制):植入物相关感染(n=648)、骨关节炎感染(1153)和 1327 例软组织感染。清创术的中位数为 1 次(范围,1-15 次干预)。总体而言,1617 例(65%)感染仅清创 1 次,862 例感染多次手术(35%)。在反复的术中组织取样中,我们在 507 例(507/862;59%)中检测到病原体,其中 241 例(242/507;48%)与首次清创时的初始菌种相对应。我们观察到 265 例新的 SSI(队列的 11%),其中 174 例(队列的 7%)对当前的抗生素治疗耐药。多变量分析显示,在当前抗生素治疗下进行的反复清创与新的 SSI 相关(比值比 1.6,95%CI 1.2-2.2);主要发生在第 2 次清创后。然而,我们未能确定在抗生素治疗期间进行理想的假设性预防以防止进一步发生 SSI。

结论

在骨科感染的反复清创过程中,经常会选择对正在进行的抗生素治疗耐药的新病原体,尤其是在第 2 次清创后。然而,新的病原体是不可预测的。如果可行,预防可能依赖于手术操作和明智的再清创指征,而不是在现有治疗方案之外增加新的最大预防性抗生素覆盖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d10e/6919616/529f08801cc2/pone.0226674.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验